MDWD - メディウ―ンド （MediWound Ltd.）

MediWound develops medical solutions for skin and burn conditions and will begin US distribution of its burn solution NexoBrid in Q3 2023. Read why I''m bullish.

MediWound Ltd. (MDWD) lost ~7% Tuesday after announcing its Q1 2023 financials that failed to meet Street forecasts. Read the full story here.

MediWound Ltd. (NASDAQ:NASDAQ:MDWD) Q1 2023 Earnings Conference Call May 30, 2023 8:30 AM ETCompany ParticipantsMonique Kosse - LifeSci Advisors, IROfer Gonen - Chief Executive OfficerHani…

Companies Reporting Before The Bell • Gaotu Techedu (NYSE: GOTU ) is projected to report earnings for its first quarter. • UP Fintech Holding (NASDAQ: TIGR ) is likely to report quarterly earnings at $0.03 per share on revenue of $45.06 million. • Elbit Systems (NASDAQ: ESLT ) is expected to report quarterly earnings at $1.73 per share on revenue of $1.39 billion. • Yatra Online (NASDAQ: YTRA ) is estimated to report quarterly loss at $0.02 per share on revenue of $12.87 million. • TH International (NASDAQ: THCH ) is projected to report earnings for its first quarter. • Skyline Champion (NYSE: SKY ) is estimated to report quarterly earnings at $0.93 per share on revenue of $528.22 million. • MediWound (NASDAQ: MDWD ) is likely to report quarterly loss at $0.30 per share on revenue of $5.15 million. • Tremor Intl (NASDAQ: TRMR ) is expected to report earnings for its first quarter. • Huize … Full story available on Benzinga.com

MediWound (NASDAQ: MDWD ) reported its Q1 earnings results on Tuesday, May 30, 2023 at 07:00 AM. Here''s what investors need to know about the announcement. Earnings MediWound missed estimated earnings by 46.67%, reporting an EPS of $-0.44 versus an … Full story available on Benzinga.com

MediWound Ltd. (NASDAQ:NASDAQ:MDWD) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ETCompany ParticipantsMonique Kosse - LifeSci Advisors, IROfer Gonen - Chief Executive…

The following slide deck was published by MediWound Ltd.

MediWound (MDWD) appointed Ms. Hani Luxenburg as its new CFO, effective May 14, 2023, replacing Mr. Boaz Gur-Lavie, who served in the role for last year years.Mr

YAVNE, Israel (AP) — YAVNE, Israel (AP) — MediWound Ltd. (MDWD) on Thursday reported a loss of $7.5 million in…

MediWound (MDWD) is scheduled to announce Q4 earnings results on Thursday, March 16th, before market open.The consensus EPS Estimate is -$0.55 (-266.7% Y/Y) and the consensus…

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO ) rose 150% to $2.0508 after the company announced it has entered into an exclusive license agreement with GSK for Spero''s late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties. HeartBeam, Inc. (NASDAQ: BEAT ) shares gained 34% to $2.12 after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO. ShiftPixy, Inc. (NASDAQ: PIXY ) shares jumped 32.4% to $18.09. ShiftPixy, on Wednesday, announced pricing of $5 million private placement. Inventiva S.A. (NASDAQ: IVA ) gained 23.7% to $4.7250 after the company reported its 2022 first-half financial results and provided a corporate update. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN ) rose 22.7% to $1.6204. Sonnet BioTherapeutics recently announced progress in Phase 1 dose-escalation trials of SON-1010.

In the current trading session, MediWound Ltd.’s (MDWD) stock is trading at the price of $1.39, a fall of -20.57% over last night’s close. So, the stock is trading at a price that is -65.34% less than its 52-week high of $4.01 and 14.88% better than its 52-week low of $1.21. Based on the past […]

Shares of Biopharmaceutical company MediWound (NASDAQ:MDWD) are tanking today owing to a registered securities offering of ~7.57 million shares and ~9.85 million warrants which will enable accredited investors in the agreement to acquire additional shares of the company. MDWD expects to raise gross proceeds of ~$30.5 million from the offerings. It plans to use the funds to scale up its facilities and for the development of EscharEx. Additionally, it could also use a part of the funds to in-license or invest into or acquire other assets.

MediWound Ltd. (MDWD) -24% on ~$30.5M securities offerings.DBV Technologies S.A

MediWound (MDWD) shares dropped 17% premarket on Thursday after the biopharmaceutical company announced ~$30.5M securities offerings.The company entered into a definitive…